These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34002449)

  • 21. Cerebrospinal fluid levels of YKL-40 in prodromal Alzheimer's disease.
    Wang L; Gao T; Cai T; Li K; Zheng P; Liu J;
    Neurosci Lett; 2020 Jan; 715():134658. PubMed ID: 31794792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of Stages of Objective Memory Impairment with Cerebrospinal Fluid and Neuroimaging Biomarkers of Alzheimer's Disease.
    Petersen KK; Ezzati A; Lipton RB; Gordon BA; Hassenstab J; Morris JC; Grober E
    J Prev Alzheimers Dis; 2023; 10(1):112-119. PubMed ID: 36641615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of APOE-ε4 and GAP-43-related presynaptic loss with β-amyloid, tau, neurodegeneration, and cognitive decline.
    Lan G; Du J; Chen X; Wang Q; ; Han Y; Guo T
    Neurobiol Aging; 2023 Dec; 132():209-219. PubMed ID: 37852045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease.
    Vemuri P; Wiste HJ; Weigand SD; Knopman DS; Shaw LM; Trojanowski JQ; Aisen PS; Weiner M; Petersen RC; Jack CR;
    Ann Neurol; 2010 Mar; 67(3):308-16. PubMed ID: 20373342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between APOE genotype, CSF Tau and cognition across the Alzheimer's disease spectrum, moderation and mediation role of insula network connectivity.
    Zhu Y; Wu Y; Lv X; Wu J; Shen C; Tang Q; Wang G;
    CNS Neurosci Ther; 2024 Jan; 30(1):e14401. PubMed ID: 37577852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease.
    Tardif CL; Devenyi GA; Amaral RSC; Pelleieux S; Poirier J; Rosa-Neto P; Breitner J; Chakravarty MM;
    Hum Brain Mapp; 2018 Feb; 39(2):971-984. PubMed ID: 29164798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Effects of the Interaction Between the Education and APOE ε4 Allele on Amyloid-beta Retention and Memory Performances in Cognitively Normal Older Adults and Alzheimer's Disease Patients.
    Kang DW; Wang SM; Na HR; Lee CU; Baek IH; Lim HK
    Curr Alzheimer Res; 2020; 17(11):1023-1032. PubMed ID: 33372875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of amyloid and tau on cortical microstructure in cognitively unimpaired adults.
    Vogt NM; Hunt JFV; Adluru N; Ma Y; Van Hulle CA; Iii DCD; Kecskemeti SR; Chin NA; Carlsson CM; Asthana S; Johnson SC; Kollmorgen G; Batrla R; Wild N; Buck K; Zetterberg H; Alexander AL; Blennow K; Bendlin BB
    Alzheimers Dement; 2022 Jan; 18(1):65-76. PubMed ID: 33984184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals.
    Yan S; Zheng C; Paranjpe MD; Li Y; Li W; Wang X; Benzinger TLS; Lu J; Zhou Y
    Brain; 2021 Nov; 144(10):3201-3211. PubMed ID: 33876815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age.
    Kester MI; Blankenstein MA; Bouwman FH; van Elk EJ; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2009; 16(3):601-7. PubMed ID: 19276554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease.
    Wattmo C; Blennow K; Hansson O
    BMC Neurol; 2020 Jan; 20(1):10. PubMed ID: 31918679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study.
    Tosun D; Schuff N; Truran-Sacrey D; Shaw LM; Trojanowski JQ; Aisen P; Peterson R; Weiner MW;
    Neurobiol Aging; 2010 Aug; 31(8):1340-54. PubMed ID: 20570401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.
    Blom ES; Giedraitis V; Zetterberg H; Fukumoto H; Blennow K; Hyman BT; Irizarry MC; Wahlund LO; Lannfelt L; Ingelsson M
    Dement Geriatr Cogn Disord; 2009; 27(5):458-64. PubMed ID: 19420940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriers.
    Benitez BA; Karch CM; Cai Y; Jin SC; Cooper B; Carrell D; Bertelsen S; Chibnik L; Schneider JA; Bennett DA; ; ; Fagan AM; Holtzman D; Morris JC; Goate AM; Cruchaga C
    PLoS Genet; 2013; 9(8):e1003685. PubMed ID: 23990795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults.
    Sible IJ; Nation DA;
    Neurology; 2022 Jun; 98(24):e2446-e2453. PubMed ID: 35418462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk.
    Ali M; Sung YJ; Wang F; Fernández MV; Morris JC; Fagan AM; Blennow K; Zetterberg H; Heslegrave A; Johansson PM; Svensson J; Nellgård B; Lleó A; Alcolea D; Clarimon J; Rami L; Molinuevo JL; Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Haass C; Ewers M; Levin J; Farlow MR; Perrin RJ; ; ; Cruchaga C
    PLoS One; 2022; 17(5):e0267298. PubMed ID: 35617280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly.
    Snellman A; Ekblad LL; Tuisku J; Koivumäki M; Ashton NJ; Lantero-Rodriguez J; Karikari TK; Helin S; Bucci M; Löyttyniemi E; Parkkola R; Karrasch M; Schöll M; Zetterberg H; Blennow K; Rinne JO
    Alzheimers Res Ther; 2023 Apr; 15(1):71. PubMed ID: 37016464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.